Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leukocare
Munich / Martinsried, Bavaria, Germanyleukocare.com ↗
- Ownership
- Private
- Employees
- ~60
- Development stage
- Commercial
01
Overview
Leukocare specializes in advanced formulation development services for biopharmaceuticals. Its proprietary SPS® technology stabilizes complex biological molecules such as proteins, antibodies, viral vectors, mRNA-LNPs, exosomes, peptides, enzymes and small molecules. The company leverages AI-driven bioinformatics and rational excipient design to improve shelf-life and efficacy while reducing risks in drug development. It collaborates with global pharma/biotech partners—including BioNTech—and has demonstrated success in extending product stability under challenging conditions.
- Modalities
- AntibodyAntibody-drug conjugateProteinPeptidesEnzyme replacement therapy (Enzyme)Virus (including viral vectors)mRNA-based drugs (mRNA-LNPs)Exosome-based therapy (Exosomes)Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
BioNTech SE – advanced formulation services for mRNA vaccine candidatesNanologica AB – collaboration on inhaled biologics using porous silica nanoparticles
Beyond the preview
Go deeper on Leukocare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leukocare.